United States · FDA National Drug Code directory
Eszopiclone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55111-619_bf1433f5-bde8-8c67-9ff7-ec5d3ed26581
- Product NDC
- 55111-619
- Form
- TABLET, COATED
- Composition / generic term
- Eszopiclone
- Labeler
- Dr. Reddy's Laboratories Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20140415
- Source listing expiry
- 20261231
Source-listed ingredients
- ESZOPICLONE — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, COATED in 1 BOTTLE (55111-619-01) · 55111-619-01
- 500 TABLET, COATED in 1 BOTTLE (55111-619-05) · 55111-619-05
- 9 BLISTER PACK in 1 CARTON (55111-619-09) / 10 TABLET, COATED in 1 BLISTER PACK (55111-619-79) · 55111-619-09
- 30 TABLET, COATED in 1 BOTTLE (55111-619-30) · 55111-619-30
- 90 TABLET, COATED in 1 BOTTLE (55111-619-90) · 55111-619-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →